Integrated Filing — IndAS

General information about company
Scrip Code	543277
NSE Symbol	LXCHEM
MSEI Symbol	NA
ISIN	INE576O01020
Name of company	LAXMI ORGANIC INDUSTRIES LIMITED
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	20-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	09-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Chemical Business
Start date and time of board meeting	20-May-2025   14:00:00
End date and time of board meeting	20-May-2025   20:30:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2022-02-01
Indicate Company website link for updated RPT policy of the Company	https://www.laxmi.com/documents/default.aspx?f=investor-relations/policy-on-materiality-of-related-party-transactions-104.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	Yes
No. of times funds raised during the quarter	2
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	Yes

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Unaudited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	7142710000	29446060000
	Other income	48500000	252930000
	Total income	7191210000	29698990000
2	Expenses
(a)	Cost of materials consumed	4713390000	19159980000
(b)	Purchases of stock-in-trade	18890000	211880000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	-47550000	-208940000
(d)	Employee benefit expense	302800000	1405190000
(e)	Finance costs	70930000	197320000
(f)	Depreciation, depletion and amortisation expense	391290000	1224940000
(f)	Other Expenses
1	Power and fuel	557630000	2324160000
2	Consumption of consumables stores and spares	38010000	194660000
3	Consumption of packing material	102240000	404810000
4	Water charges	16600000	63130000
5	Labour charges	45430000	147490000
6	Outward Export Freight Charges	231990000	936350000
7	Repairs and maintenance	66050000	206350000
8	Transportation charges	145780000	586680000
9	Commission on sales	4580000	47180000
10	other expenses	354050000	1142900000
	Total other expenses	1562360000	6053710000
	Total expenses	7012110000	28044080000
3	Total profit before exceptional items and tax	179100000	1654910000
4	Exceptional items	0	0
5	Total profit before tax	179100000	1654910000
6	Tax expense
7	Current tax	-252270000	419910000
8	Deferred tax	146620000	54790000
9	Total tax expenses	-105650000	474700000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	284750000	1180210000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	284750000	1180210000
17	Other comprehensive income net of taxes	310000	6270000
18	Total Comprehensive Income for the period	285060000	1186480000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	554050000	554050000
	Face value of equity share capital	2	2
27	Details of debt securities
22	Reserves excluding revaluation reserve		18565250000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	1.03	4.27
	Diluted earnings (loss) per share from continuing operations	1.02	4.23
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	1.03	4.27
	Diluted earnings (loss) per share from continuing and discontinued operations	1.02	4.23
24	Debt equity ratio
25	Debt service coverage ratio	0	0
26	Interest service coverage ratio	0	0
27	Disclosure of notes on financial results

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	11599190000
	Capital work-in-progress	4188290000
	Investment property	0
	Goodwill	0
	Other intangible assets	8470000
	Intangible assets under development	0
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	216610000
	Non-current financial assets
	Non-current investments	0
	Trade receivables, non-current	0
	Loans, non-current	0
	Other non-current financial assets	88440000
	Total non-current financial assets	88440000
	Deferred tax assets (net)	20980000
	Other non-current assets	550520000
	Total non-current assets	16672500000
2	Current assets
	Inventories	3586410000
	Current financial asset
	Current investments	1453930000
	Trade receivables, current	5407180000
	Cash and cash equivalents	175050000
	Bank balance other than cash and cash equivalents	766160000
	Loans, current	0
	Other current financial assets	264470000
	Total current financial assets	8066790000
	Current tax assets (net)	0
	Other current assets	2077570000
	Total current assets	13730770000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	30403270000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	554050000
	Other equity	18565250000
	Total equity attributable to owners of parent	19119300000
	Non controlling interest
	Total equity	19119300000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	425000000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	5030000
	Total non-current financial liabilities	430030000
	Provisions, non-current	76930000
	Deferred tax liabilities (net)	347560000
	Deferred government grants, Non-current	0
	Other non-current liabilities	0
	Total non-current liabilities	854520000
	Current liabilities
	Current financial liabilities
	Borrowings, current	2106710000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	230280000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	6741960000
	Total Trade payable	6972240000
	Other current financial liabilities	872120000
	Total current financial liabilities	9951070000
	Other current liabilities	87050000
	Provisions, current	43020000
	Current tax liabilities (Net)	348310000
	Deferred government grants, Current	0
	Total current liabilities	10429450000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	11283970000
	Total equity and liabilites	30403270000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Unaudited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Unaudited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Remeasurement of net defined liability	480000	9640000
	Total Amount of items that will not be reclassified to profit and loss	480000	9640000
2	Income tax relating to items that will not be reclassified to profit or loss	170000	3370000
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss	0	0
5	Total Other comprehensive income	310000	6270000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Unaudited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			1654910000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			197320000
	Adjustments for decrease (increase) in inventories			-1103460000
	Adjustments for decrease (increase) in trade receivables, current			610970000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			-714110000
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			0
	Adjustments for other financial assets, current			122060000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			-625680000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			-6330000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			1224940000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			20740000
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			52450000
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			-33910000
	Adjustments for dividend income			0
	Adjustments for interest income			84620000
	Adjustments for share-based payments			-5260000
	Adjustments for fair value losses (gains)			78490000
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			-5310000
	Other adjustments to reconcile profit (loss)			8260000
	Other adjustments for non-cash items			0
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			-263450000
	Net cash flows from (used in) operations			1391460000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			246660000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			1144800000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			860000
	Purchase of property, plant and equipment			4000990000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			0
	Interest received			69430000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) investing activities	-3930700000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			100420000
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			2477730000
	Repayments of borrowings			1303400000
	Payments of lease liabilities			21210000
	Dividends paid			165940000
	Interest paid			172900000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			1194250000
	Net cash flows from (used in) financing activities			2108950000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			-676950000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			-676950000
	Cash and cash equivalents cash flow statement at beginning of period			852000000
	Cash and cash equivalents cash flow statement at end of period			175050000

Signatory Details
Name of signatory	Aniket Hirpara
Designation of person	Company Secretary and Compliance Officer
Place	Mumbai
Date	20-May-2025